This clinical trial is assessing whether an investigational vaccine can safely and effectively prevent chlamydia infections among young adults.
The study is being conducted at our Brisbane and Canberra clinics.
This clinical research trial is evaluating an investigational oral medication designed to target a pathway involved in inflammation and pain signalling that is thought to contribute to migraines. The study aims to assess the safety and effectiveness of the investigational medication and identify the most appropriate dose for future research.
This study is being conducted at our Central Coast and Western Syndey and sites.
Apply Now
This study is exploring whether a weekly injection of an investigational medicine, taken with regular antidepressant medication, can help delay the return of major depressive disorder (MDD) symptoms. It is for adults aged 18 to 75 who are currently in remission or near remission but still experience some ongoing symptoms.
This study is only being conducted at our Melbourne site.
Apply Now
This study is evaluating an investigational medicine that may help reduce symptoms of Post Traumatic Stress Disorder (PTSD) in adults.
This study is only being conducted at our Brisbane, Canberra and Melbourne sites.
Apply Now
Researchers are studying an investigational medicine designed to evaluate whether it, when combined with healthy eating and regular physical activity, may help support long-term weight management. This study will examine the investigational medicine's safety, tolerability, and its effects on health and wellbeing over time.
This study is being conducted at our Melbourne and Brisbane clinics.
Apply Now
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
